Vaxneuvance 4 mcg (Pneumococcal Polysaccharide Serotype 6b SUSPENSION) 4 MCG

VAXNEUVANCE 4 MCG is a pneumococcal polysaccharide vaccine designed to help prevent infections caused by the pneumococcus bacteria. This intramuscular suspension is manufactured by Merck Canada Inc. and is suitable for individuals seeking protection against specific serotypes, including serotype 6B.

Strength

4 MCG

Manufacturer / TM Owner

MERCK CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

VAXNEUVANCE 4 MCG is used to help prevent infections caused by the pneumococcus bacteria. It targets specific serotypes, including serotype 6B, which can cause various illnesses. This vaccine is administered intramuscularly and is intended for individuals who may be at risk of pneumococcal infections.

Side Effects

Common effects of VAXNEUVANCE 4 MCG may include mild redness, swelling, or pain at the injection site. Some individuals might experience temporary fever, fatigue, or muscle aches. These effects are generally mild and short-lived.

Precautions & Warnings

VAXNEUVANCE 4 MCG should be administered by a healthcare professional. Individuals with a history of severe allergic reactions to any component of the vaccine should avoid its use. It is important to discuss any pre-existing medical conditions or allergies with a healthcare provider before receiving the vaccine.

Avoid Interactions

VAXNEUVANCE 4 MCG may interact with certain medications or other vaccines. It is advisable to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Specific interactions with alcohol or other substances have not been widely reported, but general precautions should be taken.

Frequently Asked Questions

VAXNEUVANCE 4 MCG is used to help prevent infections caused by the pneumococcus bacteria, including those caused by serotype 6B.

VAXNEUVANCE 4 MCG is administered intramuscularly by a healthcare professional.

Common effects may include mild redness, swelling, or pain at the injection site, as well as temporary fever, fatigue, or muscle aches.

Individuals with a history of severe allergic reactions to any component of the vaccine should avoid its use.

It is advisable to inform your healthcare provider about all medications you are taking, as VAXNEUVANCE 4 MCG may interact with certain medications or other vaccines.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.